A Multicomponent Intervention Program to Prevent and Reduce ICU Agitation and Physical Restraint Use

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorRadboud University Medical Center

About this trial

Despite deleterious effects, physical restraints are still commonly used in (expected to become) agitated patients in Dutch ICUs (20-25%). This study aims to determine the effectiveness of a person-centered multicomponent intervention (MCI) program consisting of non-pharmacological interventions combined with goal directed light sedation using dexmedetomidine compared to the old standard of care including physical restraints in (expected to become) agitated adult ICU patients.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adult ICU patients (aged ≥18) with an expected ICU stay of >24 hours

Patients who are (expected to become) agitated within the first 14 days of their ICU admission

Disqualifiers

Contra indication for dexmedetomidine use (i.e., AV-block grade 2 or 3 unless a pacemaker is present, uncontrolled hypotension, acute cerebrovascular condition or known/suspected hypersensitivity);

Neurological patients with an (expected risk of) increased intracranial pressure;

An intoxication as a result of drug abuse (e.g., ethanol, γ-Hydroxybutyrate, opioids, benzodiazepines);

Support with Extracorporeal Membrane Oxygenation (ECMO);

Trial design

Design model

Parallel

Treatments tested in this trial

  • Multicomponent intervention program

    Other intervention

    Non-pharmacological interventions combined with goal directed sedation using dexmedetomidine if needed

Treatment groups

480 Participants
are divided into 2 treatment groups
Group A: Treatment groupExperimental treatment 1 intervention
Group B: Control groupNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

ICU-free days

Time frame
28 days

Secondary outcomes

1

Incidence rate of accidentally removed medical devices

Time frame
14 days
2

Incidence rate of (self-extubation induced) reintubations

Time frame
14 days
3

Days with delirium

Assessed using the Intensive Care Delirium Screening Checklist (ICDSC), Confusion Assessment Method for the ICU (CAM-ICU), or the Delirium Observation Screening scale for the ward (DOS)

Time frame
14 days
4

Days with coma

Assessed using the Richmond Agitation and Sedation Scale (RASS)

Time frame
14 days

Other outcomes

1

Incidence rate of falls out of bed

Time frame
14 days
2

A secondary Bayesian analysis of the trial including heterogeneity of treatment effect

A secondary Bayesian analysis of the trial including heterogeneity of treatment effect

Time frame
To be conducted within one year after study completion

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Radboud University Medical Center

Lead sponsor

ZonMw: The Netherlands Organisation for Health Research and Development

Collaborator